{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:45:43Z","timestamp":1785797143274,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10689-017-9985-x","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T08:35:59Z","timestamp":1493973359000},"page":"477-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular characterization and clinical interpretation of BRCA1\/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical\u2013pathological features in BRCA carriers and non-carriers"],"prefix":"10.1007","volume":"16","author":[{"given":"Xavier","family":"Gabald\u00f3 Barrios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Desamparados","family":"Sarabia Meseguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Mar\u00edn Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"S\u00e1nchez Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Mac\u00edas Cerrolaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez Henarejos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zafra Poves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Rosario","family":"Garc\u00eda Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Cuevas Tortosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Aliaga Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Castillo Guardiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mart\u00ednez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Tovar Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Mart\u00ednez Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ayala de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Alonso Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Noguera Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ruiz Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"9985_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765\u2013781","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"9985_CR2","doi-asserted-by":"crossref","first-page":"iii30","DOI":"10.1093\/annonc\/mdq090","volume":"21","author":"MJ Sanchez","year":"2010","unstructured":"Sanchez MJ, Payer T, De AR, Larranaga N, Capocaccia R, Martinez C (2010) Cancer incidence and mortality in Spain: estimates and projections for the period 1981\u20132012. Ann Oncol 21(Suppl 3):iii30\u2013iii36","journal-title":"Ann Oncol"},{"key":"9985_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"9985_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"9985_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9985_CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665\u2013676","journal-title":"Nat Rev Cancer"},{"key":"9985_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10689-009-9301-5","volume":"9","author":"O Diez","year":"2010","unstructured":"Diez O, Gutierrez-Enriquez S, Balmana J (2010) Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing. Fam Cancer 9:187\u2013191","journal-title":"Fam Cancer"},{"key":"9985_CR8","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA 298:2869\u20132876","journal-title":"JAMA"},{"key":"9985_CR9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00439-004-1240-5","volume":"116","author":"R Kean-Cowdin","year":"2005","unstructured":"Kean-Cowdin R, Spencer FH, Xia LY et al (2005) BRCA1 variants in a family study of African\u2013American and Latina women. Hum Genet 116:497\u2013506","journal-title":"Hum Genet"},{"key":"9985_CR10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D et al (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282\u20131291","journal-title":"Hum Mutat"},{"key":"9985_CR11","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492\u20132502","journal-title":"JAMA"},{"key":"9985_CR12","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.080021","author":"CP Vaughn","year":"2008","unstructured":"Vaughn CP, Lyon E, Samowitz WS (2008) Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction. J Mol Diagn. doi: 10.2353\/jmoldx.2008.080021","journal-title":"J Mol Diagn"},{"key":"9985_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7\u201312","journal-title":"Hum Mutat"},{"key":"9985_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","volume":"18","author":"NM Lindor","year":"2013","unstructured":"Lindor NM, Goldgar DE, Tavtigian SV, Plon SE, Couch FJ (2013) BRCA1\/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist 18:518\u2013524","journal-title":"Oncologist"},{"key":"9985_CR15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10549-011-1674-0","volume":"132","author":"M Thomassen","year":"2012","unstructured":"Thomassen M, Blanco A, Montagna M et al (2012) Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Breast Cancer Res Treat 132:1009\u20131023","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.22101","volume":"33","author":"C Houdayer","year":"2012","unstructured":"Houdayer C, Caux-Moncoutier V, Krieger S et al (2012) Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat 33:1228\u20131238","journal-title":"Hum Mutat"},{"key":"9985_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/7.5.919","volume":"7","author":"MQ Zhang","year":"1998","unstructured":"Zhang MQ (1998) Statistical features of human exons and their flanking regions. Hum Mol Genet 7:919\u2013932","journal-title":"Hum Mol Genet"},{"key":"9985_CR18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput. Biol 11:377\u2013394","journal-title":"J Comput. Biol"},{"key":"9985_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput. Biol 4:311\u2013323","journal-title":"J Comput. Biol"},{"key":"9985_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.20811","volume":"30","author":"MP Vreeswijk","year":"2009","unstructured":"Vreeswijk MP, Kraan JN, van der Klift HM et al (2009) Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs. Hum Mutat 30:107\u2013114","journal-title":"Hum Mutat"},{"key":"9985_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10689-014-9708-5","volume":"13","author":"X Gabald\u00f3 Barrios","year":"2014","unstructured":"Gabald\u00f3 Barrios X, Sarabia Meseguer M, Alonso Romero JL et al (2014) Novel BRCA1 deleterious mutation (c.1918C > T) in familial breast and ovarian cancer syndrome who share a common ancestry. Fam Cancer 13:431\u2013435","journal-title":"Fam Cancer"},{"key":"9985_CR22","first-page":"2998","volume":"55","author":"H Takahashi","year":"1995","unstructured":"Takahashi H, Behbakht K, McGovern PE et al (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998\u20133002","journal-title":"Cancer Res"},{"key":"9985_CR23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","volume":"16","author":"A Musolino","year":"2007","unstructured":"Musolino A, Bella MS, Bortesi B et al (2007) BRCA mutations, molecular markers and clinical variables in early-onset breast cancer: a population based study. Breast 16:280\u2013292","journal-title":"Breast"},{"key":"9985_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-006-9376-8","volume":"103","author":"S Guti\u00e9rrez-Enr\u00edquez","year":"2007","unstructured":"Guti\u00e9rrez-Enr\u00edquez S, de la Hoya M, Martinez-Bouzas C et al (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast\/ovarian cancer. Breast Cancer Res Treat 103:103\u2013107","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O Diez","year":"2003","unstructured":"Diez O, Osorio A, Duran M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301\u2013312","journal-title":"Hum Mutat"},{"key":"9985_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:FAME.0000026816.32400.45","volume":"3","author":"J Lubinski","year":"2004","unstructured":"Lubinski J, Phelan CM, Ghadirian P et al (2004) Cancer variation associated with the possition of the mutation in the BRCA2 gene. Fam Cancer 3:1\u201310","journal-title":"Fam Cancer"},{"key":"9985_CR27","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1093\/hmg\/dds222","volume":"21","author":"K Biswas","year":"2012","unstructured":"Biswas K, Das R, EgginGton JM, Qiao H et al (2012) Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet 21:3993\u20134006","journal-title":"Hum Mol Genet"},{"key":"9985_CR28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10689-013-9622-2","volume":"4","author":"I de Juan Jim\u00e9nez","year":"2013","unstructured":"de Juan Jim\u00e9nez I, Garc\u00eda Casado Z, Palanca Suela S et al (2013) Novel and recurrent BRCA1\/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence. Fam Cancer 4:767\u2013777","journal-title":"Fam Cancer"},{"key":"9985_CR29","unstructured":"ENIGMA consortium (2015) BRCA1\/2 Gene variant classification criteria. Publishing ENIGMA consortium. https:\/\/enigmaconsortium.org\/library\/general-documents . Accessed 26 Mar 2015"},{"key":"9985_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cge.12315","volume":"86","author":"JM Eggington","year":"2014","unstructured":"Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S et al (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86:229\u2013237","journal-title":"Clin Genet"},{"issue":"1","key":"9985_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.21627","volume":"33","author":"NM Lindor","year":"2006","unstructured":"Lindor NM, Guidugli L, Wang X, Vall\u00e9e MP, Monteiro AN, Tavtiginan S, Goldgar DE, Couch FJ (2012) A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat 33(1):8\u201321","journal-title":"Hum Mutat"},{"issue":"4","key":"9985_CR32","first-page":"202","volume":"26","author":"O Diez","year":"2007","unstructured":"Diez O, Cornet M, Guti\u00e9rrez-Enr\u00edquez S et al (2007) Estudio de los genes BRCA1 y BRCA2 en 200 familias con c\u00e1ncer de mama hereditario. Qu\u00edm Cl\u00edn 26(4):202\u2013206","journal-title":"Qu\u00edm Cl\u00edn"},{"key":"9985_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10689-010-9395-9","volume":"10","author":"M Sagi","year":"2011","unstructured":"Sagi M, Eilat A, Ben AL et al (2011) Two BRCA1\/2 founder mutations in Jews of Sephardic origin. Fam Cancer 10:50\u201363","journal-title":"Fam Cancer"},{"key":"9985_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-007-9868-1","volume":"11","author":"MD Miramar","year":"2008","unstructured":"Miramar MD, Calvo MT, Rodr\u00edguez A et al (2008) Genetic analysis of BRCA1 and BRCA2 in breast\/ovarian cancer families from Aragon (Spain): two novel truncating mutation and a large genomic deletion in BRCA1. Breast Cancer Res Treat 11:353\u2013358","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10038-006-0404-7","volume":"54","author":"M Infante","year":"2006","unstructured":"Infante M, Duran M, Esteban-Cardenosa E et al (2006) High proportion of novel mutations of BRCA1 and BRCA2 in breast\/ovarian cancer patients from Castilla-Leon (central Spain). J Hum Genet 54:611\u2013617","journal-title":"J Hum Genet"},{"key":"9985_CR36","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-09-2564","volume":"16","author":"DJ Sanz","year":"2010","unstructured":"Sanz DJ, Acedo A, Infante M et al (2010) A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast\/ovarian cancer patients. Clin Cancer Res 16:1957\u20131967","journal-title":"Clin Cancer Res"},{"key":"9985_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-007-9818-y","volume":"112","author":"CE Esteban","year":"2008","unstructured":"Esteban CE, Bolufer GP, Palanca SS et al (2008) Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and\/or ovarian cancer families of Eastern Spain. Breast Cancer Res Treat 112:69\u201373","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2005.03.006","volume":"233","author":"R Salazar","year":"2006","unstructured":"Salazar R, Cruz-Hernandez JJ, Sanchez-Valdivieso E et al (2006) BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain. Cancer Lett 233:172\u2013177","journal-title":"Cancer Lett"},{"key":"9985_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavicius","year":"2010","unstructured":"Janavicius R (2010) Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1:397\u2013412","journal-title":"EPMA J"},{"key":"9985_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/humu.9014","volume":"19","author":"G Llort","year":"2002","unstructured":"Llort G, Munoz CY, Tuser MP et al (2002) Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Hum Mutat 19:307","journal-title":"Hum Mutat"},{"key":"9985_CR41","unstructured":"Breast Cancer Information Core (BIC) publishing in BIC web. http:\/\/research.nhgri.nih.gov\/bic\/ . Accessed 2013"},{"key":"9985_CR42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cancergen.2012.04.002","volume":"205","author":"J Dutil","year":"2012","unstructured":"Dutil J, Colon-Colon JL, Matta JL, Sutphen R, Echenique M (2012) Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico. Cancer Genet 205:242\u2013248","journal-title":"Cancer Genet"},{"key":"9985_CR43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.2011.41.0027","volume":"31","author":"JN Weitzel","year":"2013","unstructured":"Weitzel JN, Clague J, Martir-Negron A et al (2013) Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol 31:210\u2013216","journal-title":"J Clin Oncol"},{"key":"9985_CR44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-011-1909-0","volume":"133","author":"G Ruiz de Garibay","year":"2012","unstructured":"Ruiz de Garibay G, Gutierrez-Enriquez S, Garre P et al (2012) Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast\/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin. Breast Cancer Res Treat 133:273\u2013283","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR45","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/diacare.26.6.1752","volume":"26","author":"KB Michels","year":"2003","unstructured":"Michels KB, Solomon CG, Hu FB et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the urses Health Study. Diabetes Care 26:1752\u20131758","journal-title":"Diabetes Care"},{"key":"9985_CR46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1005831013718","volume":"47","author":"ME Del Giudice","year":"1998","unstructured":"Del Giudice ME, Fantus IG, Ezzat S et al (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111\u2013120","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"9985_CR47","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/annonc\/mdh352","volume":"15","author":"J Rogozinska-Szcepka","year":"2004","unstructured":"Rogozinska-Szcepka J, Utracka-Hutka B, Grzybowska E, Maka B, Nowicka E, Smok-Ragankiewicz A, Zientek H, Steffen J, Wojciechowska-Lacka A (2004) BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Ann Oncol 15(9):1373\u20131376","journal-title":"Ann Oncol"},{"key":"9985_CR48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/ctrv.2001.0233","volume":"27","author":"MO Nicoletto","year":"2001","unstructured":"Nicoletto MO, Donach M, de Nicolo A et al (2001) BRCA1 and BRCA2 mutations as prognostic factors in clinical practice and genetic counseling. Cancer Treat Rev 27:295\u2013304","journal-title":"Cancer Treat Rev"},{"key":"9985_CR49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/BRCA2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21:134\u2013147","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9985_CR50","unstructured":"Petrucelli N,\u00a0Daly MB, Feldman GL (1998) BRCA1\u00a0and\u00a0BRCA2\u00a0Hereditary Breast and Ovarian Cancer. Publishing GeneReviews. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247 . Accessed 26 Sept 2013"},{"key":"9985_CR51","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort G, Chirivella I, Morales R et al (2015) SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol 17:956\u2013961","journal-title":"Clin Transl Oncol"},{"key":"9985_CR52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-008-0087-1","volume":"117","author":"AL Bane","year":"2009","unstructured":"Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O' Malley FP, Andrulis IL (2009) Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumor. Breast Cancer Res Treat 117:183\u2013191","journal-title":"Breast Cancer Res Treat"},{"key":"9985_CR53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/gcc.20816","volume":"49","author":"RL Balleine","year":"2010","unstructured":"Balleine RL, Provan PJ, Pupo GM, Pathmanathan N, Cummings M, Farshid G, Salisbury EL, Bilous AM, Byth K, Mann GJ (2010) Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families. Genes Chromosomes Cancer 49:1082\u20131094","journal-title":"Genes Chromosomes Cancer"},{"key":"9985_CR54","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.3800969","volume":"20","author":"E Honrado","year":"2007","unstructured":"Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascon A, Urioste M, Cazorla A, D\u00edez O, Lerma E, Esteller M, Palacios J, Ben\u00edtez J (2007) Immunohistochemical classification of non-BRCA1\/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pahol 20:1298\u20131306","journal-title":"Mod Pahol"},{"key":"9985_CR55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2358","volume":"215","author":"PT Simpson","year":"2008","unstructured":"Simpson PT, Reis-Filho JS, Lambros MB, Jones C et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215:231\u2013244","journal-title":"J Pathol"},{"key":"9985_CR56","first-page":"782","volume":"6","author":"SR Lakhani","year":"2000","unstructured":"Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ et al (2000) The pathology of familial breast cancer: histological features of cancer in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6:782\u2013789","journal-title":"Clin Cancer Res"},{"key":"9985_CR57","unstructured":"Petrucelli N, Daly MB, Feldman GL (1998) FACMG BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer September 4, 1998. Accessed\u00a0September 26, 2013. GeneReviews\u00ae\u00a0[Internet]"},{"issue":"1","key":"9985_CR58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(14)71135-0","volume":"16","author":"A Oza","year":"2015","unstructured":"Oza A, Cibula D, Oaknin A, Poole C et al (2015) Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. The Lancet Oncology 16(1):87\u201397","journal-title":"Lancet Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-017-9985-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-9985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-9985-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T23:58:49Z","timestamp":1602028729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-017-9985-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9985"],"URL":"https:\/\/doi.org\/10.1007\/s10689-017-9985-x","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]}}}